American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008

J Dev Behav Pediatr. 2008 Aug;29(4):335. doi: 10.1097/DBP.0b013e31318185dc14.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • American Heart Association / organization & administration
  • Attention Deficit Disorder with Hyperactivity / complications
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Child
  • Electroencephalography / methods
  • Heart Diseases / complications
  • Heart Diseases / diagnosis*
  • Heart Diseases / physiopathology
  • Humans
  • Pediatrics / education
  • United States